Sharat Varma

Sharat Varma

Auto-generated profile, based on publicly available information

Sharat Varma

Novo Nordisk A/S, Vandtårnsvej 108-110, 2860 Søborg Denmark

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 February 2018 in Pediatric Transplantation
Verified
Journal Article
Closed access
PDF file
TDTanguy Demaret
Tanguy Demaret
SVSharat Varma
Sharat Varma
XSXavier Stephenne
Xavier Stephenne
FSFrançoise Smets
Françoise Smets
ISIsabelle Scheers
Isabelle Scheers
ESEtienne M Sokal
Etienne M Sokal

29 March 2023 in Journal of Hepatology
Verified
Journal Article
Closed access
RPRaluca Pais
Raluca Pais
BCBertrand Cariou
Bertrand Cariou
MNMazen Noureddin
Mazen Noureddin
SFSven M Francque
Sven M Francque
JSJörn M. Schattenberg
Jörn M. Schattenberg
VRVlad Ratziu
Vlad Ratziu

19 March 2019 in Pediatric Transplantation
Verified
Journal Article
Closed access
PDF file
NBNicolas Bonnet
Nicolas Bonnet
JPJérôme Paul
Jérôme Paul
THThibault Helleputte
Thibault Helleputte
FVFrancis Veyckemans
Francis Veyckemans
TPThierry Pirotte
Thierry Pirotte
XSXavier Stephenne
Xavier Stephenne

11 March 2021 in Pediatric Transplantation
Verified
Journal Article
Open access
PDF file
SVSharat Varma
Sharat Varma
YPYuktansh Pandey
Yuktansh Pandey
BCBhargava Ram Chikkala
Bhargava Ram Chikkala
RARajgopal Acharya
Rajgopal Acharya
SVSapana Verma
Sapana Verma
SGSubhash Gupta
Subhash Gupta
Coronavirus disease 2019 is a global pandemic, and to deal with the unexpected, enormous burden on healthcare system, liver transplantation (LT) services have been suspended in many centers. Development of robust and successful protocols in preventing the disease among the recipients, donors and healthcare workers would help in re‐starting the LT programs. We adapted a protocol at our center, which is predominantly a living donor liver transplant center based in north India, and continued the service as the pandemic unfolded and peaked in India with good results and shared the experience of the same. Between March 24 and June 7, 2020, during the government‐enforced public curfew—“lockdown”—7 children received LT. The protocols of infection control were drafted in our team by local customization of published guidelines. The number of pediatric LT done during the lockdown period in 2020 was similar to that done in corresponding pre‐COVID period in 2019. The outcomes were of 100% survival, and none of recipients developed COVID. One potential donor was asymptomatic positive for COVID, responded well to conservative treatment, and was later accepted as a donor. LT program during the COVID pandemic can successfully function after putting in place standard protocols for infection control. These can be implemented with minimal extra involvement of healthcare infrastructure, hence without diversion of resources from COVID management. In conclusion, pediatric liver transplantation services can be continued amid COVID‐19 pandemic after establishing a properly observed protocol with minimum additional resources.